Nalaganje...

The role of Asprosin in patients with dilated cardiomyopathy

BACKGROUND: Asprosin is a novel fasting glucogenic adipokine discovered in 2016. Asprosin induces rapid glucose releases from the liver. However, its molecular mechanisms and function are still unclear. Adaptation of energy substrates from fatty acid to glucose is recently considered a novel therape...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cardiovasc Disord
Main Authors: Wen, Ming-Shien, Wang, Chao-Yung, Yeh, Jih-Kai, Chen, Chun-Chi, Tsai, Ming-Lung, Ho, Ming-Yun, Hung, Kuo-Chun, Hsieh, I-Chang
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7487662/
https://ncbi.nlm.nih.gov/pubmed/32894050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-020-01680-1
Oznake: Označite
Brez oznak, prvi označite!